Sources | Names Used |
---|---|
CTRPv2 | tretinoin:navitoclax (4:1 mol/mol) |
PharmacoGx | tretinoin:navitoclax (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FXYD6 | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-10 |
mRNA | RP3-403A15.5 | CTRPv2 | pan-cancer | AAC | 0.24 | 7e-09 |
mRNA | KCNC1 | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-09 |
mRNA | C14orf132 | CTRPv2 | pan-cancer | AAC | 0.25 | 9e-09 |
mRNA | ATL1 | CTRPv2 | pan-cancer | AAC | 0.25 | 3e-11 |
mRNA | IRF2BP2 | CTRPv2 | pan-cancer | AAC | 0.25 | 3e-12 |
mRNA | SATB1 | CTRPv2 | pan-cancer | AAC | 0.25 | 7e-12 |
mRNA | ARHGAP33 | CTRPv2 | pan-cancer | AAC | 0.25 | 5e-12 |
mRNA | ELAVL4 | CTRPv2 | pan-cancer | AAC | 0.25 | 6e-07 |
mRNA | SOGA3 | CTRPv2 | pan-cancer | AAC | 0.25 | 4e-09 |